Open access · CC-BY
via OpenAlex
Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity
Yaiza Potes, Zulema Pérez-Martínez, Juan Carlos Bermejo-Millo, Adrian Rubio‐González, María Fernández Fernández, Manuel Bermúdez, Jose M. Arche, Juan J. Pérez-Solano, José Antonio Boga, Mamen Oliván, Beatriz Caballero, Ignacio Vega‐Naredo, Ana Coto‐Montes
Aging and Disease · 2018 · ▲ 40 citations
Abstract
Aging is characterized by a progressive loss of skeletal muscle mass and function (sarcopenia). Obesity exacerbates age-related decline and lead to frailty. Skeletal muscle fat infiltration increases with aging and seems to be crucial for the progression of sarcopenia. Additionally, skeletal muscle plasticity modulates metabolic adaptation to different pathophysiological situations. Thus, cellular bioenergetics and mitochondrial profile were studied in the skeletal muscle of overweight aged people without reaching obesity to prevent this extreme situation. Overweight aged muscle lacked ATP production, as indicated by defects in the phosphagen system, glycolysis and especially mostly by oxidative phosphorylation metabolic pathway. Overweight subjects exhibited an inhibition of mitophagy that was linked to an increase in mitochondrial biogenesis that underlies the accumulation of dysfunctional mitochondria and encourages the onset of sarcopenia. As a strategy to maintain cellular homeostasis, overweight subjects experienced a metabolic switch from oxidative to lactic acid fermentation metabolism, which allows continued ATP production under mitochondrial dysfunction(definition), but without reaching physiological aged basal levels. This ATP depletion induced early signs of impaired contractile function and a decline in skeletal muscle structural integrity, evidenced by lower levels of filamin C. Our findings reveal the main effector pathways at an early stage of obesity and highlight the importance of mitochondrial metabolism in overweight and obese individuals. Exploiting mitochondrial profiles for therapeutic purposes in humans is an ambitious strategy for treating muscle impairment diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14336/ad.2018.0430
- Canonical
- link ↗
- Fetched
- 2026-06-06 MST
Cite this
APA
Potes, Y., Pérez-Martínez, Z., Bermejo-Millo, J.C., Rubio‐González, A., Fernández, M.F., Bermúdez, M., Arche, J.M., Pérez-Solano, J.J., Boga, J.A., Oliván, M., Caballero, B., Vega‐Naredo, I., & Coto‐Montes, A. (2018). Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2018.0430
Vancouver
Potes Y, Pérez-Martínez Z, Bermejo-Millo JC, Rubio‐González A, Fernández MF, Bermúdez M, et al. Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity. Aging and Disease. 2018. doi:10.14336/ad.2018.0430.
BibTeX
@article{yaiza2018Overwe,
title = {Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity},
author = {Yaiza Potes and Zulema Pérez-Martínez and Juan Carlos Bermejo-Millo and Adrian Rubio‐González and María Fernández Fernández and Manuel Bermúdez and Jose M. Arche and Juan J. Pérez-Solano and José Antonio Boga and Mamen Oliván and Beatriz Caballero and Ignacio Vega‐Naredo and Ana Coto‐Montes},
journal = {Aging and Disease},
year = {2018},
doi = {10.14336/ad.2018.0430},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Free Radical Biology and Medicine 2008
Citation only
Sex-dependent differences in aged rat brain mitochondrial function and oxidative stress
Frontiers in Endocrinology 2024
Open access · CC-BY
Research progress on the correlation between estrogen and estrogen receptor on postmenopausal sarcopenia
Biology 2021
Open access · CC-BY
Mitochondrial Impairment in Sarcopenia
Pharmaceutics 2022
Open access · CC-BY
Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of Sarcopenia: Rationale and Perspectives
Nature Communications 2019
Open access · CC-BY
Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities
Genes & Development 2015
Open access · CC-BY